SI9420017B - Inhibitorji proteaze hiv-a v farmacevtskih kombinacijah za zdravljenje aids-a - Google Patents

Inhibitorji proteaze hiv-a v farmacevtskih kombinacijah za zdravljenje aids-a Download PDF

Info

Publication number
SI9420017B
SI9420017B SI9420017A SI9420017A SI9420017B SI 9420017 B SI9420017 B SI 9420017B SI 9420017 A SI9420017 A SI 9420017A SI 9420017 A SI9420017 A SI 9420017A SI 9420017 B SI9420017 B SI 9420017B
Authority
SI
Slovenia
Prior art keywords
hydroxy
substituted
alkyl
unsubstituted
aryl
Prior art date
Application number
SI9420017A
Other languages
English (en)
Slovenian (sl)
Other versions
SI9420017A (en
Inventor
Joseph P. Vacca
James P. Guare
Bruce D. Dorsey
M. Katharine Holloway
Randall W. Hungate
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Publication of SI9420017A publication Critical patent/SI9420017A/sl
Publication of SI9420017B publication Critical patent/SI9420017B/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
SI9420017A 1993-03-31 1994-03-24 Inhibitorji proteaze hiv-a v farmacevtskih kombinacijah za zdravljenje aids-a SI9420017B (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4072993A 1993-03-31 1993-03-31
PCT/US1994/003209 WO1994022480A1 (fr) 1993-03-31 1994-03-24 Inhibiteurs de la protease du vih entrant dans des preparations pharmaceutiques pour le traitement du sida

Publications (2)

Publication Number Publication Date
SI9420017A SI9420017A (en) 1996-10-31
SI9420017B true SI9420017B (sl) 2003-12-31

Family

ID=21912617

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9420017A SI9420017B (sl) 1993-03-31 1994-03-24 Inhibitorji proteaze hiv-a v farmacevtskih kombinacijah za zdravljenje aids-a

Country Status (35)

Country Link
EP (1) EP0617968B1 (fr)
JP (1) JPH08508496A (fr)
KR (1) KR100311551B1 (fr)
CN (1) CN1090186C (fr)
AT (1) ATE230610T1 (fr)
AU (1) AU685772B2 (fr)
BG (1) BG62083B1 (fr)
BR (1) BR9406503A (fr)
CA (1) CA2120192A1 (fr)
CY (1) CY2326B1 (fr)
CZ (1) CZ286412B6 (fr)
DE (1) DE69431972T2 (fr)
DK (1) DK0617968T3 (fr)
DZ (1) DZ1766A1 (fr)
ES (1) ES2188604T3 (fr)
FI (1) FI954580A0 (fr)
HK (1) HK1009248A1 (fr)
HR (1) HRP940209B1 (fr)
HU (1) HUT74006A (fr)
IL (1) IL109166A (fr)
LV (1) LV13141B (fr)
NO (1) NO953876L (fr)
NZ (1) NZ265164A (fr)
PL (1) PL310895A1 (fr)
PT (1) PT617968E (fr)
RO (1) RO118000B1 (fr)
RU (1) RU2139052C1 (fr)
SA (1) SA94140745B1 (fr)
SG (1) SG64366A1 (fr)
SI (1) SI9420017B (fr)
SK (1) SK279471B6 (fr)
TW (1) TW307684B (fr)
WO (1) WO1994022480A1 (fr)
YU (1) YU49275B (fr)
ZA (1) ZA942255B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ288312B6 (en) * 1993-12-15 2001-05-16 Merck & Co Inc HIV-protease inhibitors and pharmaceutical preparations in which they are comprised
UA49803C2 (uk) * 1994-06-03 2002-10-15 Дж.Д. Сьорль Енд Ко Спосіб лікування ретровірусних інфекцій
US5476874A (en) * 1994-06-22 1995-12-19 Merck & Co., Inc. New HIV protease inhibitors
JPH10507917A (ja) * 1994-10-25 1998-08-04 メルク エンド カンパニー インコーポレーテッド Ｈｉｖプロテアーゼ阻害剤の微生物合成
US6689761B1 (en) 1995-02-01 2004-02-10 Merck & Co., Inc. Combination therapy for HIV infection
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
PE11499A1 (es) * 1997-05-16 1999-03-01 Procter & Gamble Tratamiento del hiv y cancer
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
HU9701081D0 (en) * 1997-06-23 1997-08-28 Gene Research Lab Inc N Pharmaceutical composition of antitumoral activity
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
WO2000002862A1 (fr) 1998-07-08 2000-01-20 G.D. Searle & Co. Inhibiteurs de la protease retrovirale
AU6508899A (en) 1998-10-13 2000-05-01 Du Pont Pharmaceuticals Company Selective eradication of virally-infected cells by combined use of a cytotoxic agent and an antiviral agent
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7772271B2 (en) 2004-07-14 2010-08-10 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US8013006B2 (en) 2004-07-14 2011-09-06 Ptc Therapeutics, Inc. Methods for treating hepatitis C
US7868037B2 (en) 2004-07-14 2011-01-11 Ptc Therapeutics, Inc. Methods for treating hepatitis C
MX2007000762A (es) 2004-07-22 2007-04-02 Ptc Therapeutics Inc Tienopiridinas para tratamientode hepatitis c.
RU2520967C1 (ru) * 2013-02-08 2014-06-27 Федеральное государственное бюджетное учреждение науки Новосибирский институт органической химии им. Н.Н. Ворожцова Сибирского отделения Российской академии наук (НИОХ СО РАН) СИММЕТРИЧНЫЕ ДИИМИНЫ НА ОСНОВЕ КАМФОРЫ - ИНГИБИТОРЫ РЕПРОДУКЦИИ ВИРУСА ГРИППА (ШТАММ A/California/07/09 (H1N1)pdm09)
CN109528747A (zh) * 2018-12-13 2019-03-29 中国人民解放军总医院 扎西他滨在制备抗菌消炎药物中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06508146A (ja) * 1991-06-04 1994-09-14 スミスクライン・ビーチャム・コーポレイション 炭素環および複素環式ｈｉｖプロテアーゼ抑制剤

Also Published As

Publication number Publication date
JPH08508496A (ja) 1996-09-10
RU2139052C1 (ru) 1999-10-10
CZ286412B6 (en) 2000-04-12
HU9502860D0 (en) 1995-11-28
KR960701661A (ko) 1996-03-28
FI954580A (fi) 1995-09-27
LV13141B (en) 2004-08-20
DZ1766A1 (fr) 2002-02-17
IL109166A0 (en) 1994-06-24
CN1090186C (zh) 2002-09-04
HRP940209B1 (en) 2004-04-30
RO118000B1 (ro) 2002-12-30
SI9420017A (en) 1996-10-31
BG100016A (en) 1996-04-30
DE69431972D1 (de) 2003-02-13
CN1120316A (zh) 1996-04-10
TW307684B (fr) 1997-06-11
NO953876L (no) 1995-11-30
AU5921394A (en) 1994-10-06
HUT74006A (en) 1996-10-28
ATE230610T1 (de) 2003-01-15
NO953876D0 (no) 1995-09-29
PT617968E (pt) 2003-03-31
YU49275B (sh) 2005-03-15
CZ252895A3 (en) 1996-07-17
EP0617968A1 (fr) 1994-10-05
AU685772B2 (en) 1998-01-29
SA94140745B1 (ar) 2006-07-11
HRP940209A2 (en) 1998-02-28
EP0617968B1 (fr) 2003-01-08
ZA942255B (en) 1994-11-01
SK122595A3 (en) 1997-03-05
DK0617968T3 (da) 2003-02-24
KR100311551B1 (ko) 2001-12-28
DE69431972T2 (de) 2003-08-28
BR9406503A (pt) 1996-01-02
IL109166A (en) 1999-08-17
SK279471B6 (sk) 1998-11-04
SG64366A1 (en) 1999-04-27
ES2188604T3 (es) 2003-07-01
NZ265164A (en) 1997-09-22
PL310895A1 (en) 1996-01-08
BG62083B1 (bg) 1999-02-26
FI954580A0 (fi) 1995-09-27
CA2120192A1 (fr) 1994-10-01
WO1994022480A1 (fr) 1994-10-13
CY2326B1 (en) 2003-11-14
HK1009248A1 (en) 1999-05-28
YU15994A (sh) 1999-06-15

Similar Documents

Publication Publication Date Title
SI9420017B (sl) Inhibitorji proteaze hiv-a v farmacevtskih kombinacijah za zdravljenje aids-a
JP5227805B2 (ja) Ｉａｐ阻害剤とタキサン７の組合せ剤
AU2001281989B2 (en) Novel heteroaryl derivatives and use thereof as anti-tumour agents
AR018175A1 (es) Compuestos de indol-3-glioxilamidas sustituidas, utiles como medicamentos antitumorales, composiciones farmaceuticas formuladas con dichos derivados,utilizacion de dichos derivados para la preparacion de medicamentos antitumorales y los medicamentos asi preparados.
CN114057702B (zh) 一种新型冠状病毒主蛋白酶的抑制剂及其制备方法和用途
TR200102568T2 (tr) Amid türevleri.
CA2481369A1 (fr) Inhibiteurs de la serine protease, notamment de la protease ns3-ns4a du virus de l'hepatite c
AR039203A1 (es) Derivados de quinazolina
GB1525958A (en) 2-(heterocyclic substituted alkylsulphinyl)-benzimidazoles and their pharmaceutical compositions
RU94027563A (ru) Соединения-ингибиторы вич протеазы, их использование для лечения спида, форикомпозиция
RU2004122926A (ru) Замещенные производные хиназолина как ингибиторы ауроракиназы
TR200102959T2 (tr) İntegrin antagonistleri olarak ikame edilmiş bisiklik heteroaril bileşikleri
RU99106782A (ru) N-замещенные индол-3-глиоксиламиды, обладающие противоастматическим, противоаллергическим и иммунодепрессивным/иммуномодуляторным действием, способ их получения, применение, лекарственный препарат и способ его получения
AU2001293233A1 (en) Aza heterocyclic derivatives and their therapeutic use
CA2118195A1 (fr) Composition pharmaceutique
WO2008141385A1 (fr) Inhibiteurs de polymérases virales
KR900015729A (ko) 흥분성 아미노산 길항제
PL315035A1 (en) Cyclic amide derivatives as antagonistic substances in respect to neurokinin a
TR200000752T2 (tr) Etkin terkibin kontrollü salınımı için ilaç formülü.
FI951858A (fi) Kinoloni- ja akridonijohdannaisia virtsanpidätyskyvyttömyyden hoidossa
RU2001126725A (ru) Гетероциклические соединения, их промежуточные продукты и ингибиторы эластазы
CN105732583B (zh) 一种治疗脑胶质母细胞瘤的靶向化合物
HUP0201315A2 (hu) 4-Fenil-pirimidin-származékok, eljárás az előállításukra, alkalmazásuk és ezeket tartalmazó gyógyászati készítmények
HUP0104469A2 (hu) Szubsztituált benzo[de]izokinolin-1,3-dion-származékok, eljárás a vegyületek előállítására és ezeket tartalmazó gyógyszerkészítmények
KR930006024A (ko) 이미다조 인돌리진 유도체 및 그의 제조방법

Legal Events

Date Code Title Description
IF Valid on the event date
KO00 Lapse of patent

Effective date: 20081201